Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 36616 | 77 | 30.1 | 52% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
| 440 | 3 | NOCICEPTIN//OPIOID RECEPTORS//MORPHINE | 26600 |
| 3876 | 2 | NEUROTROPIN//BUDIPINE//HYPERVENTILATION INDUCED NYSTAGMUS | 865 |
| 36616 | 1 | BUDIPINE//1 TERT BUTYL 4 4 DIPHENYLPIPERIDINE//ADENOSINE A2 ANTAGONISTS | 77 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | BUDIPINE | authKW | 2913895 | 17% | 57% | 13 |
| 2 | 1 TERT BUTYL 4 4 DIPHENYLPIPERIDINE | authKW | 396567 | 1% | 100% | 1 |
| 3 | ADENOSINE A2 ANTAGONISTS | authKW | 396567 | 1% | 100% | 1 |
| 4 | APPARATUS OF SITUATIVE MEMORY | authKW | 396567 | 1% | 100% | 1 |
| 5 | BY 701 | authKW | 396567 | 1% | 100% | 1 |
| 6 | DIBENAMINE PSYCHOSIS | authKW | 396567 | 1% | 100% | 1 |
| 7 | DOPAMINE AGONTSTS | authKW | 396567 | 1% | 100% | 1 |
| 8 | LONG TERM TREMOR RECORDINGS | authKW | 396567 | 1% | 100% | 1 |
| 9 | MIXED LIGAND OXORHENIUM COMPLEXES | authKW | 396567 | 1% | 100% | 1 |
| 10 | NITROBENZENE SULFONYL PIPERIDINE | authKW | 396567 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Clinical Neurology | 231 | 25% | 0% | 19 |
| 2 | Pharmacology & Pharmacy | 120 | 25% | 0% | 19 |
| 3 | Neurosciences | 94 | 22% | 0% | 17 |
| 4 | Chemistry, Applied | 83 | 10% | 0% | 8 |
| 5 | Chemistry, Inorganic & Nuclear | 72 | 12% | 0% | 9 |
| 6 | Psychiatry | 53 | 10% | 0% | 8 |
| 7 | Chemistry, Organic | 51 | 13% | 0% | 10 |
| 8 | Chemistry, Medicinal | 29 | 6% | 0% | 5 |
| 9 | Chemistry, Multidisciplinary | 4 | 8% | 0% | 6 |
| 10 | Education, Scientific Disciplines | 4 | 1% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ABT FOR | 28324 | 1% | 7% | 1 |
| 2 | GONBAD KAVOOS BRANCH | 15251 | 1% | 4% | 1 |
| 3 | ST JOSEF HOSP | 6530 | 6% | 0% | 5 |
| 4 | NEUROL ABT | 2130 | 1% | 1% | 1 |
| 5 | QAEMSHAHR BRANCH | 724 | 1% | 0% | 1 |
| 6 | NEUROL KLIN | 716 | 4% | 0% | 3 |
| 7 | FOR UNGSZENTRUM ROSSENDORF EV | 551 | 1% | 0% | 1 |
| 8 | PHARM CHEM | 490 | 1% | 0% | 1 |
| 9 | STUDIES PHYS | 354 | 1% | 0% | 1 |
| 10 | PSYCHIAT KLIN | 303 | 1% | 0% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT | 12524 | 6% | 1% | 5 |
| 2 | APPLIED ORGANOMETALLIC CHEMISTRY | 8153 | 10% | 0% | 8 |
| 3 | KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII | 4013 | 10% | 0% | 8 |
| 4 | POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY | 2040 | 3% | 0% | 2 |
| 5 | JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION | 1768 | 1% | 0% | 1 |
| 6 | FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE | 1644 | 4% | 0% | 3 |
| 7 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1440 | 5% | 0% | 4 |
| 8 | NEUROPSYCHIATRIE | 1082 | 1% | 0% | 1 |
| 9 | AKTUELLE NEUROLOGIE | 885 | 3% | 0% | 2 |
| 10 | JOURNAL OF NEURAL TRANSMISSION | 872 | 4% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | PRZUNTEK, H , BITTKAU, S , BLIESATH, H , BUTTNER, U , FUCHS, G , GLASS, J , HALLER, H , KLOCKGETHER, T , KRAUS, P , LACHENMAYER, L , ET AL (2002) BUDIPINE PROVIDES ADDITIONAL BENEFIT IN PATIENTS WITH PARKINSON DISEASE RECEIVING A STABLE OPTIMUM DOPAMINERGIC DRUG REGIMEN.ARCHIVES OF NEUROLOGY. VOL. 59. ISSUE 5. P. 803 -806 | 11 | 85% | 6 |
| 2 | MULLER, T , (1998) BUDIPINE.AKTUELLE NEUROLOGIE. VOL. 25. ISSUE 7. P. 310 -313 | 12 | 80% | 0 |
| 3 | PRZUNTEK, H , MULLER, T , (1999) CLINICAL EFFICACY OF BUDIPINE IN PARKINSON'S DISEASE.JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. VOL. . ISSUE 56. P. 75 -82 | 12 | 63% | 5 |
| 4 | REICHMANN, H , (2006) BUDIPINE IN PARKINSON'S TREMOR.JOURNAL OF THE NEUROLOGICAL SCIENCES. VOL. 248. ISSUE 1-2. P. 53-55 | 8 | 73% | 3 |
| 5 | ELTZE, M , (1999) MULTIPLE MECHANISMS OF ACTION: THE PHARMACOLOGICAL PROFILE OF BUDIPINE.JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. VOL. . ISSUE 56. P. 83 -105 | 18 | 35% | 13 |
| 6 | PRZUNTEK, H , (2000) NON-DOPAMINERGIC THERAPY IN PARKINSON'S DISEASE.JOURNAL OF NEUROLOGY. VOL. 247. ISSUE . P. 19 -24 | 11 | 55% | 5 |
| 7 | MALSCH, U , BLIESATH, H , BOTHER, K , RAMM, H , LUHMANN, R , (2001) MONOTHERAPY OF PARKINSON'S DISEASE WITH BUDIPINE - A RANDOMISED DOUBLE-BLIND COMPARISION TO AMANTADINE.FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE. VOL. 69. ISSUE 2. P. 86 -+ | 5 | 83% | 3 |
| 8 | ZABLOTSKAYA, A , SEGAL, I , POPELIS, Y , MISHNEV, A , MAIOROV, M , ZABLOTSKY, D , BLUMS, E , NIKOLAJEVA, V , EZE, D , (2015) IRON OXIDE SUPERPARAMAGNETIC NANOCARRIERS BEARING AMPHIPHILIC N-HETEROCYCLIC CHOLINE ANALOGUES AS POTENTIAL ANTIMICROBIAL AGENTS.APPLIED ORGANOMETALLIC CHEMISTRY. VOL. 29. ISSUE 6. P. 376 -383 | 6 | 38% | 2 |
| 9 | BIGGS, CS , STARR, MS , (1999) MICRODIALYSIS STUDY OF THE EFFECTS OF THE ANTIPARKINSONIAN DRUG BUDIPINE ON L-DOPA-INDUCED RELEASE OF DOPAMINE AND 5-HYDROXYTRYPTAMINE BY RAT SUBSTANTIA NIGRA AND CORPUS STRIATUM.SYNAPSE. VOL. 34. ISSUE 1. P. 36 -46 | 10 | 30% | 8 |
| 10 | LUKEVICS, E , ZABLOTSKAYA, A , SEGAL, I , GERMANE, S , POPELIS, J , (2003) SILYL MODIFICATION OF BIOLOGICALLY ACTIVE COMPOUNDS. 9. SYNTHESIS AND BIOLOGICAL ACTIVITY OF NOVEL DERIVATIVES OF, 1,3-DISILABENZO[5,6]CYCLOHEXENE.KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII. VOL. . ISSUE 6. P. 941 -947 | 4 | 67% | 0 |
Classes with closest relation at Level 1 |